News Perha-Pharmaceuticals Home > Perha Pharmaceuticals is a laureate of the European Innovation Council (EIC) Accelerator Programme and could receive an €8 M in funding for the development of its lead candidate Leucettinib-21 > Perha-Pharmaceuticals 15 September 2022
